CTEV MultiPlan Corp

NYSE multiplan.us


$ 69.69 $ 3.27 (4.92 %)    

Friday, 24-Oct-2025 18:26:42 EDT
QQQ $ 617.50 $ 6.52 (1.07 %)
DIA $ 472.45 $ 4.92 (1.05 %)
SPY $ 677.25 $ 5.49 (0.82 %)
TLT $ 91.47 $ 0.04 (0.04 %)
GLD $ 378.59 $ -1.27 (-0.34 %)
$ 69.69
$ 67.00
$ 63.92 x 1
$ 75.00 x 42
$ 66.27 - $ 71.49
$ 4.80 - $ 74.07
159,381
na
1.15B
$ 0.85
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-09-2025 03-31-2025 10-Q
3 02-26-2025 12-31-2024 10-K
4 11-06-2024 09-30-2024 10-Q
5 08-02-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 02-29-2024 12-31-2023 10-K
8 11-08-2023 09-30-2023 10-Q
9 08-03-2023 06-30-2023 10-Q
10 05-10-2023 03-31-2023 10-Q
11 03-01-2023 12-31-2022 10-K
12 11-09-2022 09-30-2022 10-Q
13 08-05-2022 06-30-2022 10-Q
14 05-10-2022 03-31-2022 10-Q
15 02-25-2022 12-31-2021 10-K
16 11-04-2021 09-30-2021 10-Q
17 08-06-2021 06-30-2021 10-Q
18 05-14-2021 03-31-2021 10-Q
19 03-16-2021 12-31-2020 10-K
20 11-13-2020 09-30-2020 10-Q
21 08-12-2020 06-30-2020 10-Q
22 05-12-2020 03-31-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Citigroup analyst Daniel Grosslight upgrades Claritev (NYSE:CTEV) from Neutral to Buy and raises the price target from $55 t...

Core News & Articles

Citigroup analyst Daniel Grosslight upgrades Claritev (NYSE:CTEV) from Neutral to Buy and announces $55 price target.

Core News & Articles

As of October 15, 2025, Claritev Corporation (the "Company") has successfully renewed contracts with its ten largest cl...

Core News & Articles

Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused...

Core News & Articles

Piper Sandler analyst Jessica Tassan maintains Claritev (NYSE:CTEV) with a Overweight and raises the price target from $44 t...

Core News & Articles

 – SEC Filing

Core News & Articles

2025 Financial GuidanceThe Company is updating its full-year 2025 guidance, detailed in the table below:Financial Metric FY 202...

Core News & Articles

Piper Sandler analyst Jessica Tassan upgrades Claritev (NYSE:CTEV) from Neutral to Overweight and raises the price target fr...

Core News & Articles

This agreement follows the previous announcement of a memorandum of understanding signed last month.Claritev Corporation ("...

Core News & Articles

Claritev (NYSE:CTEV) reported quarterly losses of $(4.38) per share which missed the analyst consensus estimate of $(2.20) by 9...

Core News & Articles

The partnership integrates Claritev's innovative solutions with Lantern's Specialty Care Platform to optimize healthcar...

Core News & Articles

Piper Sandler analyst Jessica Tassan maintains Claritev (NYSE:CTEV) with a Neutral and raises the price target from $10 to $19.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION